4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-24-003966
General Counsel, Secretary acquired 28,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Perone Thomas Michael General Counsel, Secretary | 2024-02-22 | Grant or award | +28,125 | 28,125 | D | ||
| Derivatives | |||||||
| Perone Thomas Michael General Counsel, Secretary | 2024-02-22 | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | D | ||
Loading xslF345X05/doc4.xml…